A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
一项 Ib 期首次人体研究,旨在评估 Ponsegromab 在癌症合并恶病质患者中的安全性、耐受性、药代动力学和药效学。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1631
Crawford, Jeffrey; Calle, Roberto A; Collins, Susie M; Weng, Yan; Lubaczewski, Shannon L; Buckeridge, Clare; Wang, Ellen Q; Harrington, Magdalena A; Tarachandani, Anil; Rossulek, Michelle I; Revkin, James H